PSYCHOGENICS AND SOSEI PARTNER TO IDENTIFY NEW CNS THERAPIES
PsychoGenics Inc., Tarrytown, NY and Sosei Co. Ltd., Japan, have entered into
a drug discovery collaboration combining Sosei's Drug Reprofiling Platform and
PsychoGenics' proprietary Drug Discovery Systems. This collaboration aims to
rapidly discover and bring to market new CNS therapies.